AMA Approves 2 New CPT Codes for COVID-19

New CPT Codes for COVID-19

One of the codes, CPT Code 99072, is for reporting additional supplies used to mitigate spread of the virus.

The American Medical Association (AMA) announced, Sept. 8, two new Category I CPT® codes to meet the changing needs of the healthcare industry brought about by the COVID-19 public health emergency (PHE). The codes were approved by the CPT® Editorial Panel for immediate use during the PHE for COVID-19.

New Special Services, Procedures, and Reports Code

CPT Code 99072 Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency as defined by law, due to respiratory-transmitted infectious disease

CPT code 99072 encompasses the additional supplies, materials, and clinical staff time required to support safe in-person patient interactions with healthcare professionals during the PHE for COVID-19. Unless extended, the PHE for COVID-19 expires Oct. 25.

As explained in a Sept. 8 CPT® Assistant Special Edition, use 99072 only when safety measures are over and above those usually included during an office visit or service (as opposed to CPT code 99070, which covers supplies, materials, and time used during a typical office visit).

Additional coding guidelines for CPT Code 99072:

  • The time counted in any other time-based visit or service during the same encounter cannot be counted twice to report this code.
  • You do not need to link the code to a particular diagnosis code such as ICD-10-CM U07.1 COVID-19.
  • You may report 99072 with an evaluation and management (E/M) service or procedure even if it is not PHE-related.
  • You may report 99072 only once per in-person patient encounter per Provider Identification Number (PIN).

New Pathology and Laboratory Code

CPT code 86413 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative

CPT code 86413 was approved in response to the development of laboratory tests that provide quantitative measurements of SARS-CoV-2 antibodies, as opposed to a qualitative assessment (positive/negative) of SAR-CoV-2 antibodies provided by laboratory tests reported by other CPT® codes.

By measuring antibodies to the virus, the tests reported by 86413 can investigate a person’s adaptive immune response to the virus and help access the effectiveness of treatments used against the coronavirus.

Standard Protocol

Per the standard early release delivery process for CPT® codes, you will need to manually upload the code descriptors into your electronic health record (EHR) system. These CPT® codes will most likely arrive as part of the complete CPT® code set in the data file for 2021 later this year; however, due to the fluid nature of the novel coronavirus, it is important to stay abreast of updates from the AMA as they are released. Always check with your payer for coverage of new codes.

For More Information: